Merck & Co Inc (LTS:0QAH)
$ 131.3 0 (0%) Market Cap: 249.37 Bil Enterprise Value: 272.91 Bil PE Ratio: 20.67 PB Ratio: 5.61 GF Score: 81/100

Merck & Co Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 06:15PM GMT
Release Date Price: $107.7
Terence C. Flynn
Morgan Stanley, Research Division - Equity Analyst

Hi, everybody. Thanks for joining us this afternoon. I'm Terence Flynn, the U.S. biopharma analyst here at Morgan Stanley. We're very pleased to be hosting Merck this afternoon. We have Dean Li, who is President of Merck Research Labs; and Caroline Litchfield, who is the company's CFO.

Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Well, thanks both so much for being here today. Really appreciate it. A pleasure to be hosting the company today.

Questions & Answers

Terence C. Flynn
Morgan Stanley, Research Division - Equity Analyst

Maybe Caroline, I thought we'd start off with the business. Obviously, it's been performing exceptionally well here. Maybe just help us think about the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot